Skip to main content

Collagen chosen to take part in €4m research project

Collagen chosen to take part in €4m research project

Collagen Solutions has been chosen to take part in a €4 million (£2.9m) European research project aimed at developing new treatments for Parkinson’s disease.

The company said it will receive “significant funding” to develop various types of medical-grade collagens for investigation during the project, which is looking to progress treatments that are aimed at slowing the progression of the disease rather than just alleviating the symptoms.

The project is being led by CÚRAM, the Centre for Research in Medical Devices based at National University for Ireland in Galway, and is bringing together world-class researchers and industry partners to develop the first disease-modifying therapy for Parkinson’s, which could slow down its progression.

See the article in full at scotsman.com